ストックスクリーナーアプリを入手
1.37
5.38%
0.07
前日終値:
$1.30
開ける：
$1.29
24時間の取引高:
22,042
Relative Volume:
0.23
時価総額：
$3.91M
収益：
$202.00K
当期純損益:
$-28.96M
株価収益率:
-2.2833
EPS:
-0.6
ネットキャッシュフロー:
$-21.85M
1週間 パフォーマンス:
-2.84%
1か月 パフォーマンス:
-47.51%
6か月 パフォーマンス:
+1,344%
1年 パフォーマンス:
+547.14%
1日の値動き範囲:
$1.26
$1.37
1週間の範囲:
$1.26
$1.4598
52週間の値動き範囲:
$0.0633
$20.35
AIM ImmunoTech Inc Stock (AIM) Company Profile
AIM を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
AIM
AIM ImmunoTech Inc
|
1.37 | 3.59M | 202.00K | -28.96M | -21.85M | -0.60 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
AIM ImmunoTech Inc (AIM) 最新ニュース
What analyst consensus implies for AIM ImmunoTech Inc. (HXB) stock2025 Fundamental Recap & Daily Volume Surge Trade Alerts - newser.com
Why global investors buy AIM ImmunoTech Inc. stockWeekly Stock Report & Daily Oversold Bounce Ideas - newser.com
Why AIM ImmunoTech Inc. stock fits value portfoliosJuly 2025 Levels & Community Trade Idea Sharing Platform - newser.com
Will AIM ImmunoTech Inc. (HXB) stock deliver stable dividends2025 Technical Overview & Risk Adjusted Buy/Sell Alerts - newser.com
How AIM ImmunoTech Inc. (HXB) stock behaves under inflation pressureMarket Movers & Real-Time Chart Breakout Alerts - newser.com
Is AIM ImmunoTech Inc. (HXB) stock vulnerable to rate hikesQuarterly Portfolio Report & Safe Capital Growth Tips - newser.com
Can AIM ImmunoTech Inc. stock deliver strong annual returnsJuly 2025 Highlights & AI Based Buy/Sell Signal Reports - newser.com
Is AIM ImmunoTech Inc. stock a buy on weaknessJuly 2025 Movers & Real-Time Volume Analysis - newser.com
Can AIM ImmunoTech Inc. (HXB) stock resist broad market declines2025 Market Outlook & Technical Pattern Alert System - newser.com
Is AIM ImmunoTech Inc. (HXB) stock bottoming after sell offGDP Growth & Step-by-Step Trade Execution Guides - newser.com
AIM ImmunoTech Enters Note Purchase Agreement - TipRanks
Aim ImmunoTech enters Note Purchase Agreement with Streeterville Capital, says SEC filing - MarketScreener
Is AIM ImmunoTech Inc. stock a buy before new product rollout2025 Price Targets & Precise Trade Entry Recommendations - newser.com
Is AIM ImmunoTech Inc. (HXB) stock resilient in recession scenariosJuly 2025 Volume & Trade Opportunity Analysis Reports - newser.com
AIM ImmunoTech Reports Third Quarter 2025 Financial Results and Highlights Continued Progress Across Pipeline with Strategic Focus on Pancreatic Cancer Clinical Program - The Manila Times
AIM ImmunoTech reports third quarter 2025 financial results and highlights continued progress across pipeline with strategic focus on pancreatic cancer clinical program - MarketScreener
AIM ImmunoTech (NYSE American: AIM) Q3 2025 highlights pancreatic cancer Ampligen program, $2.4M cash - Stock Titan
AIM ImmunoTech Reports Q3 2025 Financial Results - TipRanks
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Can AIM ImmunoTech Inc. stock expand revenue streamsWeekly Stock Analysis & Capital Efficiency Focused Ideas - newser.com
AIM ImmunoTech Inc (AIM) 財務データ
収益
当期純利益
現金流量
EPS
1.38%
1.42%
大文字化:
|
ボリューム (24 時間):